BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25889404)

  • 1. Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.
    El-Bassossy HM; Watson ML
    J Transl Med; 2015 Mar; 13():82. PubMed ID: 25889404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet.
    Jia G; Habibi J; Bostick BP; Ma L; DeMarco VG; Aroor AR; Hayden MR; Whaley-Connell AT; Sowers JR
    Hypertension; 2015 Mar; 65(3):531-9. PubMed ID: 25489061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
    Xu D; Murakoshi N; Tajiri K; Duo F; Okabe Y; Murakata Y; Yuan Z; Li S; Aonuma K; Song Z; Shimoda Y; Mori H; Sato A; Nogami A; Aonuma K; Ieda M
    Clin Sci (Lond); 2021 Oct; 135(20):2409-2422. PubMed ID: 34386810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine Alleviates I/R-Induced Intestinal Injury and Dysmotility Via the Downregulation of Xanthine Oxidase/Uric Acid Signaling and Lactate Generation in Wistar Rats.
    Akhigbe RE; Adedamola Aminat BO; Akhigbe TM; Hamed MA
    J Surg Res; 2024 Mar; 295():431-441. PubMed ID: 38070257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.
    Schmidt HM; Wood KC; Lewis SE; Hahn SA; Williams XM; McMahon B; Baust JJ; Yuan S; Bachman TN; Wang Y; Oh JY; Ghosh S; Ofori-Acquah SF; Lebensburger JD; Patel RP; Du J; Vitturi DA; Kelley EE; Straub AC
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):769-782. PubMed ID: 33267657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dipeptidyl peptidase-4 averts free fatty acids deposition in the hearts of oral estrogen-progestin contraceptive-induced hyperinsulinemic female rats.
    Adegoke TE; Sabinari IW; Areola ED; Ajao F; Asafa OO; Soluoku TK; Bello A; Adesanmi AM; Yusuf SO; Omoleye A; Ayinla MT; Olatunji LA
    Can J Physiol Pharmacol; 2021 Dec; 99(12):1316-1323. PubMed ID: 34310895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The compelling role of allopurinol in hyperuricemia-induced epilepsy: Unrecognized like tears in rain.
    AlAseeri AA; Al-Kuraishy HM; Al-Gareeb AI; Ali NH; Alexiou A; Papadakis M; Bahaa MM; Alruwaili M; Batiha GE
    Brain Res Bull; 2024 Jul; 213():110973. PubMed ID: 38723694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
    Pacher P; Nivorozhkin A; Szabó C
    Pharmacol Rev; 2006 Mar; 58(1):87-114. PubMed ID: 16507884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD.
    Sun M; Hines N; Scerbo D; Buchanan J; Wu C; Ten Eyck P; Zepeda-Orozco D; Taylor EB; Jalal DI
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance.
    Salim S; Asghar M; Chugh G; Taneja M; Xia Z; Saha K
    Brain Res; 2010 Nov; 1359():178-85. PubMed ID: 20816762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic voyage of synthetic and natural xanthine oxidase inhibitors.
    Agrawal N; Arya M; Kushwah P
    Chem Biol Drug Des; 2023 Nov; 102(5):1293-1307. PubMed ID: 37550063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Differences in XO (Xanthine Oxidase) and Mitochondrial DNA Damage-Associated Molecular Patterns in Resistant Hypertension.
    Butts B; Brown JA; Denney TS; Ballinger S; Lloyd SG; Oparil S; Sanders P; Merriman TR; Gaffo A; Singh J; Kelley EE; Calhoun DA; Dell'Italia LJ
    Hypertension; 2022 Apr; 79(4):775-784. PubMed ID: 35164526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of maslinic acid and gallic acid compounds as xanthine oxidase inhibitors in isoprenaline administered myocardial necrotic rats.
    Shaik AH; Shaik SR; Shaik AS; Daoud A; Salim M; Kodidhela LD
    Saudi J Biol Sci; 2021 Apr; 28(4):2575-2580. PubMed ID: 33911968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension.
    Cristóbal-García M; García-Arroyo FE; Tapia E; Osorio H; Arellano-Buendía AS; Madero M; Rodríguez-Iturbe B; Pedraza-Chaverrí J; Correa F; Zazueta C; Johnson RJ; Lozada LG
    Oxid Med Cell Longev; 2015; 2015():535686. PubMed ID: 25918583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Febuxostat on Oxidative Stress.
    Fukui T; Maruyama M; Yamauchi K; Yoshitaka S; Yasuda T; Abe Y
    Clin Ther; 2015 Jul; 37(7):1396-401. PubMed ID: 25913922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.
    Givertz MM; Anstrom KJ; Redfield MM; Deswal A; Haddad H; Butler J; Tang WH; Dunlap ME; LeWinter MM; Mann DL; Felker GM; O'Connor CM; Goldsmith SR; Ofili EO; Saltzberg MT; Margulies KB; Cappola TP; Konstam MA; Semigran MJ; McNulty SE; Lee KL; Shah MR; Hernandez AF;
    Circulation; 2015 May; 131(20):1763-71. PubMed ID: 25986447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.
    Kanji T; Gandhi M; Clase CM; Yang R
    BMC Nephrol; 2015 Apr; 16():58. PubMed ID: 25928556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the hepatoprotective effects of hesperidin on liver-associated disorders in albino rats with experimentally induced obesity and type II diabetes: A histological and biochemical study.
    Atta IS; Elnady MR; Alghamdi AG; Alghamdi AH; Aboulata AA; Shatla IM
    Heliyon; 2023 May; 9(5):e16031. PubMed ID: 37215885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the relationship between serum xanthine oxidase levels and type 2 diabetes: a cross-sectional study.
    Hasan M; Fariha KA; Barman Z; Mou AD; Miah R; Habib A; Tuba HR; Ali N
    Sci Rep; 2022 Dec; 12(1):20816. PubMed ID: 36460780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics Based on
    Yang Y; Qian J; Li B; Lu M; Le G; Xie Y
    Foods; 2021 Oct; 10(10):. PubMed ID: 34681487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.